NCT04616183 2025-12-23
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
M.D. Anderson Cancer Center
Eli Lilly and Company